Article Text
Abstract
Trials using children as subjects are much more problematic from an informed consent perspective than trials on competent adults, although the ‘therapeutic misconception’ is a central concern in both. The role of famous experiments and the use of one individual's experience to designate and justify a whole category of research have always threatened to undermine the validity of informed consent to research by making it seem to be a validated therapy. In research, the unintended consequence of ‘naming’ based on goals (‘cure’) or specific individuals (like the Mississippi Baby) tends to subvert informed consent when the famous case is a ‘success’, and to prematurely end a line of research if the named subject dies. Names, including the Mississippi Baby, Barney Clark, Baby Fae and even Martin Delaney, are more suggestive of fantasy than science. The word ‘cure’ should not be used in obtaining consent for HIV ‘cure trials’, and names of people involved in past experiments should be avoided in the informed consent process. These two modest proposals should reduce the risks of the therapeutic misconception in ‘cure research’.
- Informed Consent
- Research Ethics
- Children
- HIV Infection and AIDS
- Research on Special Populations
Statistics from Altmetric.com
Footnotes
Funding National Institute of Allergy and Infectious Diseases.
Competing interests None declared.
Provenance and peer review Commissioned; externally peer reviewed.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
Read the full text or download the PDF:
Other content recommended for you
- Beyond informed consent: the therapeutic misconception and trust
- Informed consent to HIV cure research
- Uterus transplantation: ethical and regulatory challenges
- Understanding, interests and informed consent: a reply to Sreenivasan
- Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk / benefit assessment
- Cultural considerations for informed consent in paediatric research in low / middle - income countries: a scoping review
- Donor - funded research: permissible, not perfect
- Vulnerability, therapeutic misconception and informed consent: is there a need for special treatment of pregnant women in fetus - regarding clinical trials
- Are patients with amyotrophic lateral sclerosis at risk of a therapeutic misconception
- Informed consent for functional MRI research on comatose patients following severe brain injury: balancing the social benefits of research against patient autonomy